4
Changes in Ownership
LENZ Therapeutics, Inc. Filed Acc 0001209191-22-004346
10% owner bought 97,670 shares at an average $9.10 ($888,677)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Samsara BioCapital, L.P. 10% owner | 2022-01-19 | Purchase | +54,565 | $9.24 | $504,181 | 7,868,745 | I |
| Samsara BioCapital, L.P. 10% owner | 2022-01-20 | Purchase | +43,105 | $8.92 | $384,497 | 7,911,850 | I |
| Open-market purchases · 97,670 sh · avg $9.10 · $888,677 | |||||||
Loading xslF345X03/doc4.xml…